TP53 and neoplasm: In superficial tubal intraepithelial cancer (STIC), which is an accepted progenitor lesion for HGSTOC, mutations in the somatic TP53 tumor suppressor gene constitute the so-called “p53 signature”, which unexpectedly was also confirmed in the benign tubal epithelium of BRCA mutation carriers and normal controls.